SNA
55
3
IR
72
3
ADSK
75
10
AZO
50
7
NI
58
-2
WDC
53
3
MRK
56
-7
CCI
34
-7
MTB
46
2
AN
52
6
NKE
42
3
TAP
31
2
SLB
37
5
LRCX
81
3
GPS
63
4
VFC
38
-9
NEE
44
-2
ETN
78
5
COST
74
2
PFG
37
3
SNA
55
3
IR
72
3
ADSK
75
10
AZO
50
7
NI
58
-2
WDC
53
3
MRK
56
-7
CCI
34
-7
MTB
46
2
AN
52
6
NKE
42
3
TAP
31
2
SLB
37
5
LRCX
81
3
GPS
63
4
VFC
38
-9
NEE
44
-2
ETN
78
5
COST
74
2
PFG
37
3
Financhill
Back

Berkshire Hathaway Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
35

BRK.A
Berkshire Hathaway

Last Price:
613,560.01
Seasonality Move:
4.6%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Sell
35
Berkshire Hathaway (BRK.A) is a Sell

Is Berkshire Hathaway a Buy, Sell or Hold?

  • The current Berkshire Hathaway [BRK.A] share price is $613,860.00. The Score for BRK.A is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRK.A Stock Price Chart

What is Berkshire Hathaway's stock price today?

  • The Berkshire Hathaway share price today is $613,860.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -729.98 Sell
Relative Strength Index (14 RSI): 47.03 Sell
Chaikin Money Flow: 2538 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (619046.92 - 619058.92) Sell
Bollinger Bands (100): (612481.36 - 612507.36) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 615951.48 Sell
20-day SMA: 617939.15 Sell
50-day SMA: 614895.65 Sell
200-day SMA: 576679.14 Buy
8-day EMA: 615065.77 Sell
20-day EMA: 616707.99 Sell
50-day EMA: 615062.73 Sell
200-day EMA: 581367.65 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $528.81 per share, a decrease next quarter of $597.70 per share, an increase this year of $5,835.55 per share, and an increase next year of $1,492.03 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Berkshire Hathaway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):